Peripheral blood absolute lymphocyte count at diagnosis is an effective biomarker that can be used to risk-stratify patients with multiple myeloma, according to retrospective study results.

These tests look for how much m-protein is in your blood, and what kind of m-protein you have. People with MGUS do not have symptoms or signs of multiple myeloma. Some people feel peripheral ...

Black Americans have double the risk of developing multiple myeloma compared to white Americans and are diagnosed at younger ages.

Nevertheless, one may encounter an occasional patient suffering from multiple myeloma who manifests a striking ... All agglutination tests using blood cells as antigen were recorded after four ...

A research team from the Heidelberg Medical Faculty, the German Cancer Research Center (DKFZ), the Berlin Institute of Health ...

The analysis of 11,427 Veterans Administration (VA) hospital patients with multiple myeloma (MM ... microenvironment are reflected in the peripheral blood lymphocyte count and peripheral blood ...

The phase 2 REST trial by Frida Bugge Askeland and colleagues, reported in The Lancet Haematology, provides insight into ...